GSK CEO: Drug debate 'overly focused' on price
Share

GSK CEO: Drug debate 'overly focused' on price

GlaxoSmithKline CEO Sir Andrew Witty discusses the drug environment as pressure mounts over higher prices.
02:48
Tue, Nov 3 20153:10 PM EST